HALOPERIDOL LACTATE

HALOPERIDOL LACTATE was reported 24939 times

HALOPERIDOL LACTATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MYOCARDIAL REPERFUSION INJURY 18 0.4737
1 PAROXYSMAL PERCEPTUAL ALTERATION 27 0.4500
2 ENCEPHALITIS TOXIC 19 0.2405
3 MALIGNANT CATATONIA 63 0.2395
4 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 158 0.2287
5 DELUSION OF GRANDEUR 80 0.1782
6 REFUSAL OF EXAMINATION 21 0.1603
7 SPASMODIC DYSPHONIA 46 0.1518
8 NEUROLEPTIC MALIGNANT SYNDROME 1677 0.1413
9 WAXY FLEXIBILITY 24 0.1364
10 COGWHEEL RIGIDITY 105 0.1000
11 DISINHIBITION 153 0.0950
12 CATATONIA 455 0.0866
13 ECHOLALIA 25 0.0786
14 COLONIC PSEUDO-OBSTRUCTION 20 0.0717
15 OSCILLOPSIA 18 0.0695
16 OROMANDIBULAR DYSTONIA 49 0.0672
17 ANTICHOLINERGIC SYNDROME 106 0.0665
18 NEGLECT OF PERSONAL APPEARANCE 16 0.0658
19 BREATHING-RELATED SLEEP DISORDER 15 0.0633
20 GRANDIOSITY 21 0.0574
21 PSYCHOTIC SYMPTOM 116 0.0561
22 RESTING TREMOR 36 0.0557
23 SCHIZOPHRENIA, PARANOID TYPE 20 0.0556
24 VISCERAL CONGESTION 28 0.0548
25 OCULOGYRIC CRISIS 116 0.0540
26 PROTRUSION TONGUE 31 0.0532
27 WATER INTOXICATION 26 0.0514
28 EXTRAPYRAMIDAL DISORDER 1271 0.0511
29 EMOTIONAL POVERTY 84 0.0479
30 DRUG-GENETIC INTERACTION 17 0.0476
31 SCHIZOAFFECTIVE DISORDER 85 0.0476
32 SEXUALLY INAPPROPRIATE BEHAVIOUR 22 0.0472
33 AKATHISIA 634 0.0464
34 LYMPHOCYTE COUNT ABNORMAL 52 0.0462
35 MUTISM 67 0.0461
36 PARKINSONIAN GAIT 28 0.0449
37 NEGATIVISM 33 0.0435
38 SCHIZOPHRENIA 524 0.0431
39 PARKINSONISM 413 0.0423
40 BLUNTED AFFECT 31 0.0420
41 BLOOD PROLACTIN ABNORMAL 36 0.0417
42 VERBAL ABUSE 20 0.0407
43 POSTURING 21 0.0404
44 TORTICOLLIS 85 0.0401
45 HYPERPROLACTINAEMIA 257 0.0396
46 MASKED FACIES 16 0.0394
47 PERSECUTORY DELUSION 92 0.0369
48 NEPHROGENIC DIABETES INSIPIDUS 42 0.0364
49 ENCEPHALITIS AUTOIMMUNE 47 0.0357
50 MUSCLE RIGIDITY 424 0.0354
51 EMBOLISM VENOUS 103 0.0339
52 PRIAPISM 117 0.0339
53 SALIVARY HYPERSECRETION 337 0.0337
54 DYSTONIA 653 0.0336
55 ANTIPSYCHOTIC DRUG LEVEL INCREASED 93 0.0330
56 THERAPEUTIC PRODUCT EFFECT VARIABLE 124 0.0319
57 SEDATION COMPLICATION 80 0.0313
58 METABOLIC SYNDROME 51 0.0310
59 BORDERLINE PERSONALITY DISORDER 22 0.0310
60 APALLIC SYNDROME 22 0.0303
61 MULTIPLE DRUG THERAPY 22 0.0292
62 OPISTHOTONUS 23 0.0289
63 HYPERREFLEXIA 100 0.0287
64 PSYCHOMOTOR RETARDATION 80 0.0284
65 AUTONOMIC NERVOUS SYSTEM IMBALANCE 83 0.0284
66 STUPOR 88 0.0274
67 HALLUCINATION, AUDITORY 430 0.0270
68 DELUSIONAL DISORDER, UNSPECIFIED TYPE 20 0.0267
69 CHOLINERGIC SYNDROME 17 0.0266
70 HYPERAMMONAEMIC ENCEPHALOPATHY 46 0.0264
71 HYPOPARATHYROIDISM 20 0.0261
72 TORSADE DE POINTES 203 0.0258
73 RESPIRATORY ALKALOSIS 42 0.0258
74 DELUSION 399 0.0257
75 ADENOMA BENIGN 22 0.0256
76 OBSESSIVE-COMPULSIVE DISORDER 202 0.0251
77 SEDATION 650 0.0248
78 SYMPTOM MASKED 18 0.0247
79 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 22 0.0247
80 PRESSURE OF SPEECH 16 0.0246
81 FEELING GUILTY 32 0.0242
82 HYPORESPONSIVE TO STIMULI 28 0.0238
83 ANOSOGNOSIA 18 0.0234
84 ILEUS PARALYTIC 104 0.0233
85 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 52 0.0232
86 GRIMACING 18 0.0230
87 DELIRIUM 791 0.0228
88 COMPULSIVE SEXUAL BEHAVIOUR 18 0.0222
89 NUCHAL RIGIDITY 20 0.0221
90 CHOREA 38 0.0220
91 HYPOTHERMIA 223 0.0220
92 PSYCHOTIC DISORDER 648 0.0219
93 LIP EROSION 16 0.0219
94 DIET REFUSAL 16 0.0218
95 CIRCADIAN RHYTHM SLEEP DISORDER 18 0.0217
96 APRAXIA 32 0.0216
97 HYPERTHERMIA 164 0.0215
98 DYSLIPIDAEMIA 108 0.0212
99 STEREOTYPY 20 0.0212
100 ELECTROCARDIOGRAM PR PROLONGATION 16 0.0209
101 DEMENTIA WITH LEWY BODIES 23 0.0207
102 REDUCED FACIAL EXPRESSION 20 0.0197
103 BRADYKINESIA 116 0.0196
104 GAZE PALSY 33 0.0194
105 HYPERTONIA 109 0.0190
106 ELECTROCARDIOGRAM QT PROLONGED 683 0.0190
107 PAROTITIS 22 0.0189
108 CLONUS 50 0.0183
109 RHINALGIA 50 0.0182
110 ACUTE PSYCHOSIS 45 0.0182
111 POLYDIPSIA 71 0.0179
112 TONIC CLONIC MOVEMENTS 23 0.0177
113 EUPHORIC MOOD 179 0.0175
114 CONSCIOUSNESS FLUCTUATING 18 0.0172
115 MEGACOLON 27 0.0172
116 MYOCARDITIS 197 0.0172
117 NEUTROPHIL COUNT INCREASED 173 0.0169
118 PSYCHIATRIC DECOMPENSATION 33 0.0169
119 EOSINOPHIL COUNT DECREASED 40 0.0168
120 HEAD TITUBATION 23 0.0167
121 BLOOD PROLACTIN INCREASED 78 0.0165
122 DROOLING 114 0.0165
123 SEROTONIN SYNDROME 316 0.0164
124 GRANULOCYTOPENIA 93 0.0163
125 VULVOVAGINAL CANDIDIASIS 22 0.0163
126 COMA SCALE ABNORMAL 47 0.0162
127 DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL 27 0.0159
128 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 41 0.0156
129 VICTIM OF CRIME 19 0.0154
130 MYOCLONUS 183 0.0153
131 PSYCHOMOTOR HYPERACTIVITY 254 0.0153
132 LABILE BLOOD PRESSURE 18 0.0152
133 BLOOD CREATINE PHOSPHOKINASE INCREASED 432 0.0150
134 HYPERTHERMIA MALIGNANT 22 0.0148
135 HALLUCINATIONS, MIXED 62 0.0147
136 SOCIAL AVOIDANT BEHAVIOUR 82 0.0142
137 AKINESIA 29 0.0140
138 URETERIC OBSTRUCTION 19 0.0139
139 DISTRACTIBILITY 16 0.0139
140 RESUSCITATION 23 0.0139
141 ELECTROENCEPHALOGRAM ABNORMAL 43 0.0136
142 TARDIVE DYSKINESIA 384 0.0136
143 INTESTINAL DILATATION 18 0.0135
144 ILLUSION 22 0.0133
145 MANIA 216 0.0131
146 ELECTROCARDIOGRAM T WAVE ABNORMAL 20 0.0128
147 BLOOD PHOSPHORUS DECREASED 46 0.0126
148 PITUITARY TUMOUR BENIGN 20 0.0123
149 DRUG CLEARANCE DECREASED 16 0.0122
150 AGITATION 895 0.0122
151 TROPONIN I INCREASED 20 0.0120
152 HYPERAMMONAEMIA 60 0.0120
153 AGGRESSION 599 0.0120
154 AFFECTIVE DISORDER 94 0.0119
155 SELF INJURIOUS BEHAVIOUR 36 0.0118
156 PNEUMONIA ASPIRATION 294 0.0118
157 SUDDEN CARDIAC DEATH 40 0.0117
158 BEHAVIOUR DISORDER 63 0.0116
159 HYPERNATRAEMIA 58 0.0116
160 STARING 28 0.0116
161 POSTURE ABNORMAL 37 0.0114
162 INAPPROPRIATE AFFECT 18 0.0113
163 HYPERKINESIA 24 0.0113
164 RENAL NEOPLASM 24 0.0113
165 VENTRICULAR ARRHYTHMIA 41 0.0112
166 REFUSAL OF TREATMENT BY PATIENT 73 0.0112
167 BLOOD BICARBONATE DECREASED 21 0.0111
168 HOSTILITY 28 0.0110
169 DRUG LEVEL INCREASED 181 0.0109
170 DRUG INTERACTION 1732 0.0109
171 METABOLIC DISORDER 63 0.0108
172 RHABDOMYOLYSIS 450 0.0108
173 FAECALOMA 59 0.0108
174 TONGUE BITING 22 0.0107
175 VENOUS THROMBOSIS LIMB 22 0.0107
176 IMPULSIVE BEHAVIOUR 40 0.0106
177 LEUKOCYTOSIS 192 0.0106
178 PARADOXICAL DRUG REACTION 39 0.0106
179 CATAPLEXY 15 0.0106
180 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 108 0.0105
181 THERAPEUTIC AGENT TOXICITY 35 0.0105
182 COMMUNICATION DISORDER 40 0.0104
183 HYPOREFLEXIA 20 0.0104
184 LONG QT SYNDROME 25 0.0104
185 HYPERSEXUALITY 19 0.0104
186 MENTAL IMPAIRMENT 252 0.0104
187 PARANOIA 179 0.0104
188 INCREASED APPETITE 198 0.0104
189 CEREBRAL ATROPHY 41 0.0103
190 HYPOTONIA NEONATAL 16 0.0102
191 OBESITY 163 0.0102
192 RESTLESSNESS 373 0.0102
193 RESPIRATORY ACIDOSIS 40 0.0102
194 PARAPARESIS 18 0.0101
195 TRISMUS 52 0.0101
196 HYPERLACTACIDAEMIA 27 0.0101
197 BRAIN DEATH 31 0.0100
198 ALTERED STATE OF CONSCIOUSNESS 216 0.0100
199 ANTICONVULSANT DRUG LEVEL INCREASED 16 0.0099
200 DEPRESSED LEVEL OF CONSCIOUSNESS 391 0.0099
201 SOPOR 128 0.0097
202 DEPRESSIVE SYMPTOM 34 0.0096
203 SUICIDE ATTEMPT 584 0.0096
204 HYPERCAPNIA 29 0.0096
205 PANCREATITIS NECROTISING 22 0.0096
206 PHYSICAL ASSAULT 20 0.0096
207 POTENTIATING DRUG INTERACTION 32 0.0095
208 SUDDEN DEATH 100 0.0094
209 VOLVULUS 22 0.0093
210 TIC 50 0.0092
211 GESTATIONAL DIABETES 43 0.0090
212 DRUG MONITORING PROCEDURE NOT PERFORMED 16 0.0089
213 OBSESSIVE THOUGHTS 16 0.0089
214 TACHYPNOEA 120 0.0088
215 DYSKINESIA 358 0.0088
216 SINUS TACHYCARDIA 125 0.0088
217 SINUS BRADYCARDIA 85 0.0088
218 MENTAL STATUS CHANGES 244 0.0088
219 LEUKOPENIA 437 0.0087
220 GALACTORRHOEA 56 0.0087
221 LEUKAEMIA 82 0.0087
222 COLITIS ISCHAEMIC 58 0.0086
223 VENTRICULAR FIBRILLATION 94 0.0085
224 INTENTIONAL SELF-INJURY 170 0.0084
225 MUSCLE CONTRACTURE 17 0.0084
226 MIOSIS 67 0.0083
227 ENCEPHALOPATHY 205 0.0083
228 RESPIRATORY DEPRESSION 101 0.0082
229 TREATMENT NONCOMPLIANCE 450 0.0082
230 DIABETIC COMA 23 0.0082
231 BLOOD SODIUM INCREASED 22 0.0081
232 HYPERVENTILATION 47 0.0081
233 BRAIN INJURY 81 0.0081
234 EYE MOVEMENT DISORDER 55 0.0080
235 MUCOSAL DRYNESS 16 0.0079
236 SELF-INJURIOUS IDEATION 33 0.0079
237 TOXIC EPIDERMAL NECROLYSIS 118 0.0078
238 UNRESPONSIVE TO STIMULI 200 0.0077
239 BIPOLAR I DISORDER 17 0.0077
240 IMPAIRED SELF-CARE 16 0.0077
241 MUSCLE CONTRACTIONS INVOLUNTARY 27 0.0077
242 LYMPHOCYTE COUNT INCREASED 25 0.0077
243 FEMORAL NECK FRACTURE 39 0.0076
244 DYSARTHRIA 283 0.0075
245 KLEBSIELLA INFECTION 38 0.0075
246 DRUG TOXICITY 102 0.0075
247 ACCIDENTAL EXPOSURE 31 0.0074
248 NEUROTOXICITY 130 0.0074
249 BRUXISM 40 0.0074
250 SLOW SPEECH 18 0.0074
251 LOGORRHOEA 26 0.0074
252 HYPOMANIA 27 0.0073
253 TACHYCARDIA 651 0.0073
254 ASPIRATION 80 0.0073
255 STAPHYLOCOCCAL SEPSIS 36 0.0073
256 PRESCRIBED OVERDOSE 141 0.0073
257 HYPONATRAEMIA 408 0.0072
258 ELECTROCARDIOGRAM T WAVE INVERSION 16 0.0072
259 TENSION 44 0.0072
260 ENDOTRACHEAL INTUBATION 20 0.0071
261 ABNORMAL BEHAVIOUR 282 0.0071
262 TROPONIN INCREASED 54 0.0071
263 HYPOVENTILATION 23 0.0071
264 SELF-MEDICATION 29 0.0070
265 DRUG LEVEL ABOVE THERAPEUTIC 32 0.0070
266 BLOOD CHLORIDE DECREASED 18 0.0070
267 BUNDLE BRANCH BLOCK RIGHT 32 0.0070
268 REBOUND EFFECT 78 0.0069
269 PSYCHOMOTOR SKILLS IMPAIRED 18 0.0069
270 URINARY RETENTION 227 0.0068
271 BRADYPHRENIA 44 0.0067
272 TOXICITY TO VARIOUS AGENTS 1134 0.0067
273 PULSELESS ELECTRICAL ACTIVITY 28 0.0067
274 HAEMODYNAMIC INSTABILITY 51 0.0067
275 LYMPHOCYTE COUNT DECREASED 118 0.0067
276 GENERALISED TONIC-CLONIC SEIZURE 109 0.0066
277 DISORIENTATION 260 0.0066
278 LEFT VENTRICULAR HYPERTROPHY 28 0.0065
279 POISONING 82 0.0065
280 COMA 309 0.0065
281 PENIS DISORDER 16 0.0065
282 CARDIAC DYSFUNCTION 24 0.0064
283 HOMICIDAL IDEATION 26 0.0064
284 IMMOBILE 28 0.0064
285 NYSTAGMUS 34 0.0064
286 SUSPECTED SUICIDE 30 0.0064
287 VENTRICULAR HYPERTROPHY 16 0.0064
288 HALLUCINATION, VISUAL 133 0.0063
289 COGNITIVE DISORDER 294 0.0063
290 NEPHROGENIC ANAEMIA 29 0.0063
291 CARDIO-RESPIRATORY ARREST 261 0.0062
292 PSYCHIATRIC SYMPTOM 46 0.0062
293 WHITE BLOOD CELL COUNT INCREASED 239 0.0062
294 GASTROINTESTINAL NECROSIS 18 0.0062
295 DRUG LEVEL BELOW THERAPEUTIC 34 0.0062
296 SEXUAL DYSFUNCTION 72 0.0061
297 BRONCHOPNEUMONIA 21 0.0061
298 HALLUCINATION 461 0.0061
299 PERSONALITY DISORDER 16 0.0061
300 APATHY 89 0.0061
301 ALCOHOL ABUSE 16 0.0060
302 BRADYCARDIA 317 0.0060
303 SCREAMING 38 0.0060
304 TONGUE DISORDER 43 0.0059
305 DYSPHORIA 30 0.0059
306 BLOOD ALBUMIN DECREASED 47 0.0059
307 GAMBLING DISORDER 16 0.0059
308 BUNDLE BRANCH BLOCK LEFT 25 0.0059
309 ISCHAEMIA 27 0.0059
310 BRAIN OEDEMA 74 0.0059
311 AGRANULOCYTOSIS 108 0.0058
312 WRONG PATIENT RECEIVED PRODUCT 17 0.0058
313 MONOCYTE COUNT INCREASED 21 0.0058
314 TACHYPHRENIA 20 0.0058
315 HYPERPHAGIA 23 0.0058
316 AZOTAEMIA 23 0.0058
317 INCOHERENT 37 0.0057
318 BIPOLAR DISORDER 62 0.0057
319 ORTHOPNOEA 18 0.0056
320 CACHEXIA 29 0.0056
321 MAJOR DEPRESSION 41 0.0056
322 VENTRICULAR TACHYCARDIA 92 0.0056
323 COMPLETED SUICIDE 463 0.0056
324 SNORING 21 0.0055
325 DRUG RESISTANCE 142 0.0055
326 TOXIC ENCEPHALOPATHY 28 0.0055
327 WEIGHT INCREASED 1230 0.0055
328 DYSPHEMIA 24 0.0055
329 CARDIAC ARREST 450 0.0054
330 ENURESIS 22 0.0054
331 PERIORBITAL OEDEMA 28 0.0054
332 CARDIOPULMONARY FAILURE 21 0.0054
333 LEFT VENTRICULAR DYSFUNCTION 36 0.0054
334 RESPIRATORY FAILURE 388 0.0053
335 CEREBROVASCULAR DISORDER 16 0.0053
336 REBOUND ACID HYPERSECRETION 16 0.0053
337 HYPOXIA 185 0.0052
338 MULTIPLE DRUG OVERDOSE 26 0.0052
339 VENTRICULAR EXTRASYSTOLES 54 0.0052
340 BREAST ENLARGEMENT 17 0.0052
341 ORTHOSTATIC HYPOTENSION 90 0.0052
342 CYANOSIS 81 0.0051
343 HYPERTRIGLYCERIDAEMIA 30 0.0051
344 INCONTINENCE 54 0.0051
345 NEUTROPHILIA 29 0.0051
346 ACUTE RESPIRATORY FAILURE 98 0.0051
347 PETIT MAL EPILEPSY 26 0.0051
348 GRAND MAL CONVULSION 47 0.0051
349 FIBRIN D DIMER INCREASED 18 0.0051
350 URINARY INCONTINENCE 150 0.0051
351 ATAXIA 60 0.0051
352 PROTEIN TOTAL DECREASED 19 0.0050
353 ACUTE PULMONARY OEDEMA 28 0.0050
354 MYDRIASIS 64 0.0050
355 EATING DISORDER 103 0.0048
356 OLIGURIA 30 0.0048
357 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 16 0.0048
358 THERAPY PARTIAL RESPONDER 75 0.0048
359 CARDIAC FAILURE ACUTE 32 0.0048
360 CARDIOMYOPATHY 71 0.0048
361 INTENTIONAL OVERDOSE 308 0.0048
362 EOSINOPHIL COUNT INCREASED 40 0.0048
363 ASPHYXIA 39 0.0048
364 CONFUSIONAL STATE 769 0.0048
365 APNOEA 37 0.0047
366 PLATELET COUNT INCREASED 61 0.0047
367 RESPIRATORY DISTRESS 129 0.0047
368 THINKING ABNORMAL 87 0.0047
369 TYPE 1 DIABETES MELLITUS 28 0.0046
370 ELECTROLYTE IMBALANCE 54 0.0046
371 PULSE ABSENT 22 0.0046
372 SUICIDAL BEHAVIOUR 19 0.0046
373 THROMBOPHLEBITIS 16 0.0046
374 AMMONIA INCREASED 23 0.0045
375 ATRIOVENTRICULAR BLOCK COMPLETE 30 0.0045
376 BLOOD TRIGLYCERIDES INCREASED 79 0.0045
377 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 17 0.0044
378 PHOTOPSIA 28 0.0044
379 ILEUS 55 0.0044
380 ATRIAL FLUTTER 35 0.0044
381 LETHARGY 252 0.0044
382 NEUTROPHIL COUNT DECREASED 178 0.0044
383 HYPERCHOLESTEROLAEMIA 42 0.0043
384 BLOOD UREA INCREASED 72 0.0043
385 MENTAL DISORDER 187 0.0043
386 POLYURIA 35 0.0043
387 TREMOR 707 0.0043
388 SPEECH DISORDER 223 0.0043
389 HYPERPYREXIA 18 0.0042
390 THERAPY NON-RESPONDER 191 0.0042
391 FAILURE TO THRIVE 22 0.0042
392 SUICIDAL IDEATION 384 0.0042
393 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 40 0.0042
394 METABOLIC ACIDOSIS 134 0.0042
395 SOMNOLENCE 843 0.0042
396 GASTRIC INFECTION 16 0.0042
397 INTESTINAL ISCHAEMIA 23 0.0042
398 CIRCULATORY COLLAPSE 71 0.0042
399 SARS-COV-2 TEST POSITIVE 55 0.0042
400 STEVENS-JOHNSON SYNDROME 92 0.0041
401 MYOCARDIAL ISCHAEMIA 47 0.0041
402 C-REACTIVE PROTEIN INCREASED 150 0.0041
403 HYPOTONIA 41 0.0041
404 ELECTROCARDIOGRAM ABNORMAL 32 0.0041
405 BODY TEMPERATURE INCREASED 83 0.0041
406 NEUTROPENIA 553 0.0041
407 RESPIRATORY RATE INCREASED 36 0.0041
408 ENCEPHALITIS 28 0.0040
409 MUSCLE TWITCHING 93 0.0040
410 HYPERTRANSAMINASAEMIA 28 0.0040
411 ODYNOPHAGIA 24 0.0040
412 JAW DISORDER 22 0.0040
413 EOSINOPHILIA 70 0.0040
414 RENAL TUBULAR NECROSIS 39 0.0040
415 EPILEPSY 121 0.0040
416 PULMONARY EMBOLISM 370 0.0039
417 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 100 0.0039
418 HYPOKALAEMIA 179 0.0039
419 IRRITABILITY 229 0.0038
420 DYSPHAGIA 361 0.0038
421 COORDINATION ABNORMAL 53 0.0038
422 DERMATITIS EXFOLIATIVE 19 0.0038
423 BLOOD LACTIC ACID INCREASED 20 0.0038
424 PULMONARY CONGESTION 50 0.0038
425 FOOD POISONING 20 0.0037
426 ACUTE RESPIRATORY DISTRESS SYNDROME 66 0.0037
427 COVID-19 PNEUMONIA 44 0.0037
428 SUBSTANCE ABUSE 30 0.0037
429 BLOOD CHOLESTEROL ABNORMAL 17 0.0037
430 NORMAL NEWBORN 20 0.0037
431 DRUG ABUSE 304 0.0036
432 UMBILICAL HERNIA 17 0.0036
433 RESPIRATORY ARREST 99 0.0036
434 GLOMERULAR FILTRATION RATE DECREASED 44 0.0036
435 MUCOSAL INFLAMMATION 93 0.0035
436 GENERAL PHYSICAL CONDITION ABNORMAL 24 0.0035
437 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 193 0.0035
438 SEPTIC SHOCK 153 0.0035
439 LUNG INFILTRATION 31 0.0035
440 DEMENTIA 98 0.0035
441 PERICARDIAL EFFUSION 81 0.0035
442 WITHDRAWAL SYNDROME 147 0.0035
443 PSEUDOMONAS INFECTION 30 0.0035
444 CEREBRAL ISCHAEMIA 18 0.0035
445 HYPERGLYCAEMIA 127 0.0035
446 HAEMOLYTIC ANAEMIA 31 0.0035
447 HEPATOCELLULAR INJURY 49 0.0035
448 DRUG LEVEL DECREASED 35 0.0034
449 MULTIPLE MYELOMA 16 0.0034
450 POST-TRAUMATIC STRESS DISORDER 23 0.0034
451 INFLAMMATORY MARKER INCREASED 17 0.0034
452 MOVEMENT DISORDER 110 0.0034
453 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 243 0.0034
454 DISTURBANCE IN ATTENTION 184 0.0034
455 HEPATITIS ACUTE 22 0.0034
456 ERYSIPELAS 17 0.0034
457 CHOKING 66 0.0034
458 HYPOMAGNESAEMIA 47 0.0034
459 ATRIOVENTRICULAR BLOCK 26 0.0034
460 HYPOALBUMINAEMIA 26 0.0033
461 MOTOR DYSFUNCTION 34 0.0033
462 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 25 0.0033
463 AFFECT LABILITY 32 0.0033
464 RENAL FAILURE ACUTE 141 0.0033
465 URINE OUTPUT DECREASED 29 0.0033
466 ACUTE KIDNEY INJURY 507 0.0033
467 ACUTE HEPATIC FAILURE 45 0.0033
468 VARICOSE VEIN 17 0.0033
469 RENAL CELL CARCINOMA 16 0.0033
470 BLOOD ALKALINE PHOSPHATASE INCREASED 81 0.0033
471 MULTIPLE ORGAN DYSFUNCTION SYNDROME 92 0.0032
472 HYPOPHAGIA 83 0.0032
473 MEDICATION ERROR 180 0.0032
474 HYPOKINESIA 47 0.0032
475 DIABETIC NEUROPATHY 16 0.0032
476 IMPAIRED GASTRIC EMPTYING 44 0.0032
477 BLOOD LACTATE DEHYDROGENASE INCREASED 51 0.0032
478 HEPATIC ENCEPHALOPATHY 30 0.0032
479 DIABETES MELLITUS 245 0.0032
480 GLUCOSE TOLERANCE IMPAIRED 19 0.0032
481 ANGIOPATHY 18 0.0032
482 TYPE 2 DIABETES MELLITUS 108 0.0032
483 ASPARTATE AMINOTRANSFERASE INCREASED 170 0.0032
484 DECUBITUS ULCER 26 0.0032
485 RESTLESS LEGS SYNDROME 58 0.0032
486 DERMATITIS BULLOUS 23 0.0032
487 HAEMATOCRIT DECREASED 63 0.0032
488 SHOCK 73 0.0032
489 GASTROENTERITIS 46 0.0031
490 CARDIOTOXICITY 28 0.0031
491 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 16 0.0031
492 NO THERAPEUTIC RESPONSE 38 0.0031
493 WRONG PRODUCT ADMINISTERED 21 0.0031
494 HAEMODIALYSIS 26 0.0031
495 ARRHYTHMIA 146 0.0031
496 BLOOD SODIUM DECREASED 58 0.0031
497 ABNORMAL WEIGHT GAIN 38 0.0031
498 NERVOUS SYSTEM DISORDER 96 0.0031
499 SEIZURE 355 0.0031
500 HYDRONEPHROSIS 23 0.0031
501 END STAGE RENAL DISEASE 56 0.0031
502 RASH MACULO-PAPULAR 68 0.0031
503 DISSEMINATED INTRAVASCULAR COAGULATION 43 0.0031
504 UROSEPSIS 28 0.0030
505 RENAL CYST 24 0.0030
506 ALANINE AMINOTRANSFERASE INCREASED 185 0.0030
507 BLOOD CREATININE INCREASED 196 0.0030
508 ATELECTASIS 29 0.0030
509 ORAL DISORDER 22 0.0030
510 HYPOTENSION 597 0.0030
511 PERICARDITIS 50 0.0030
512 LIVER FUNCTION TEST ABNORMAL 86 0.0030
513 NEUTROPENIC SEPSIS 21 0.0029
514 MATERNAL EXPOSURE BEFORE PREGNANCY 20 0.0029
515 TRANSAMINASES INCREASED 65 0.0029
516 AMENORRHOEA 51 0.0029
517 HYPOGLYCAEMIA 140 0.0029
518 TUBULOINTERSTITIAL NEPHRITIS 54 0.0029
519 DISSOCIATION 22 0.0029
520 METASTASES TO CENTRAL NERVOUS SYSTEM 37 0.0029
521 HYPERLIPIDAEMIA 34 0.0028
522 PRODUCT PACKAGING ISSUE 27 0.0028
523 CLOSTRIDIUM DIFFICILE COLITIS 30 0.0028
524 SWOLLEN TONGUE 88 0.0028
525 GENERAL PHYSICAL HEALTH DETERIORATION 324 0.0028
526 DIABETIC KETOACIDOSIS 67 0.0028
527 CARDIOGENIC SHOCK 40 0.0028
528 MALNUTRITION 31 0.0028
529 CONDITION AGGRAVATED 836 0.0027
530 SEPSIS 306 0.0027
531 PURPURA 24 0.0027
532 MUSCULOSKELETAL STIFFNESS 236 0.0027
533 CONVULSION 153 0.0027
534 HYPERHIDROSIS 344 0.0027
535 JOINT DISLOCATION 28 0.0026
536 LOSS OF CONSCIOUSNESS 339 0.0026
537 DRUG DISPENSING ERROR 40 0.0026
538 GAMMA-GLUTAMYLTRANSFERASE INCREASED 58 0.0026
539 THROMBOCYTOPENIA 292 0.0026
540 SOMNAMBULISM 17 0.0026
541 STATUS EPILEPTICUS 29 0.0026
542 ANURIA 22 0.0026
543 BLOOD MAGNESIUM DECREASED 22 0.0025
544 BODY TEMPERATURE DECREASED 25 0.0025
545 HEPATIC CYTOLYSIS 32 0.0025
546 CONJUNCTIVITIS 46 0.0025
547 ERECTILE DYSFUNCTION 63 0.0025
548 HYPOGAMMAGLOBULINAEMIA 16 0.0024
549 CEREBRAL DISORDER 18 0.0024
550 HYPERCALCAEMIA 30 0.0024
551 MULTI-ORGAN FAILURE 42 0.0024
552 DRUG DIVERSION 15 0.0024
553 HYPOTHYROIDISM 77 0.0024
554 HAEMATEMESIS 61 0.0024
555 OVERDOSE 517 0.0024
556 PYREXIA 829 0.0024
557 LOW BIRTH WEIGHT BABY 19 0.0024
558 DEPRESSED MOOD 126 0.0024
559 TOXIC SKIN ERUPTION 24 0.0024
560 WHITE BLOOD CELL COUNT DECREASED 258 0.0024
561 HYPOCALCAEMIA 45 0.0024
562 HYPERSOMNIA 68 0.0024
563 PERSONALITY CHANGE 22 0.0024
564 HEMIPARESIS 40 0.0024
565 RENAL FAILURE 313 0.0024
566 ACIDOSIS 18 0.0024
567 ORAL CANDIDIASIS 31 0.0024
568 RENAL FAILURE CHRONIC 18 0.0023
569 PLEURAL EFFUSION 142 0.0023
570 MYOPATHY 20 0.0023
571 PANCREATITIS ACUTE 52 0.0023
572 PELVIC FRACTURE 18 0.0023
573 SPINAL COMPRESSION FRACTURE 19 0.0023
574 ACUTE CORONARY SYNDROME 19 0.0023
575 PRODUCT ADMINISTRATION INTERRUPTED 18 0.0023
576 CELLULITIS 115 0.0023
577 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 39 0.0023
578 FEAR 61 0.0023
579 PULMONARY OEDEMA 101 0.0023
580 BLOOD DISORDER 18 0.0022
581 EYELID OEDEMA 26 0.0022
582 HYPERKALAEMIA 78 0.0022
583 ANAL INCONTINENCE 20 0.0022
584 TREATMENT FAILURE 184 0.0022
585 MITRAL VALVE INCOMPETENCE 25 0.0022
586 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 15 0.0022
587 LOWER RESPIRATORY TRACT INFECTION 100 0.0022
588 SUPRAVENTRICULAR TACHYCARDIA 21 0.0022
589 ACCIDENTAL OVERDOSE 80 0.0022
590 ECONOMIC PROBLEM 33 0.0022
591 RESPIRATORY DISORDER 65 0.0022
592 METASTASES TO LUNG 25 0.0022
593 MUSCLE TIGHTNESS 35 0.0022
594 RENAL IMPAIRMENT 181 0.0022
595 DRUG SCREEN POSITIVE 17 0.0021
596 HEPATIC STEATOSIS 40 0.0021
597 PNEUMOTHORAX 34 0.0021
598 HYPERTENSION 454 0.0021
599 PRODUCT USE IN UNAPPROVED INDICATION 530 0.0021
600 THERAPY CHANGE 21 0.0021
601 CHOLESTASIS 41 0.0021
602 HOSPICE CARE 21 0.0021
603 APHASIA 64 0.0021
604 FACIAL PARALYSIS 18 0.0021
605 HEPATOTOXICITY 47 0.0021
606 AMNESIA 137 0.0021
607 BLOOD POTASSIUM INCREASED 34 0.0021
608 MATERNAL DRUGS AFFECTING FOETUS 16 0.0021
609 EMOTIONAL DISORDER 64 0.0021
610 HYPERTHYROIDISM 30 0.0021
611 PLATELET COUNT DECREASED 220 0.0021
612 PALLOR 56 0.0021
613 CHRONIC KIDNEY DISEASE 156 0.0021
614 GASTRITIS 54 0.0021
615 LYMPHOPENIA 29 0.0020
616 SKIN INFECTION 23 0.0020
617 NEPHROPATHY TOXIC 23 0.0020
618 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 18 0.0020
619 INTERNATIONAL NORMALISED RATIO INCREASED 58 0.0020
620 CONSTIPATION 442 0.0020
621 CARDIAC FAILURE 162 0.0020
622 ANXIETY 573 0.0020
623 SPUTUM DISCOLOURED 19 0.0020
624 EJECTION FRACTION DECREASED 31 0.0020
625 OXYGEN SATURATION DECREASED 111 0.0020
626 EXPOSURE DURING PREGNANCY 122 0.0020
627 DRUG WITHDRAWAL SYNDROME 172 0.0020
628 SLEEP DISORDER 138 0.0020
629 HICCUPS 16 0.0019
630 ANGIOEDEMA 86 0.0019
631 ANOREXIA 25 0.0019
632 GYNAECOMASTIA 60 0.0019
633 EMBOLISM 16 0.0019
634 LIVE BIRTH 16 0.0019
635 UPPER GASTROINTESTINAL HAEMORRHAGE 32 0.0019
636 ACUTE MYOCARDIAL INFARCTION 56 0.0019
637 CAESAREAN SECTION 22 0.0019
638 RED BLOOD CELL COUNT DECREASED 54 0.0019
639 INTESTINAL OBSTRUCTION 71 0.0019
640 PRODUCT ADMINISTRATION ERROR 38 0.0019
641 HEPATITIS 48 0.0019
642 ASCITES 55 0.0019
643 BLOOD CALCIUM DECREASED 21 0.0019
644 ANHEDONIA 49 0.0019
645 SLUGGISHNESS 19 0.0019
646 DEEP VEIN THROMBOSIS 121 0.0019
647 INTENTIONAL PRODUCT MISUSE 163 0.0019
648 GENERALISED OEDEMA 23 0.0019
649 BLOOD TEST ABNORMAL 26 0.0018
650 PYELONEPHRITIS 16 0.0018
651 HYPERBILIRUBINAEMIA 19 0.0018
652 HEPATOMEGALY 18 0.0018
653 DRUG WITHDRAWAL SYNDROME NEONATAL 27 0.0018
654 PANCYTOPENIA 101 0.0018
655 PNEUMONIA 585 0.0018
656 ARTERIOSCLEROSIS 17 0.0018
657 INSOMNIA 479 0.0018
658 HYPERTENSIVE CRISIS 20 0.0018
659 FRACTURE 34 0.0018
660 CYTOKINE RELEASE SYNDROME 36 0.0018
661 POISONING DELIBERATE 17 0.0018
662 SPLENOMEGALY 21 0.0018
663 APHONIA 25 0.0018
664 CARDIOMEGALY 22 0.0018
665 EMPHYSEMA 18 0.0018
666 CONTRAINDICATED PRODUCT ADMINISTERED 54 0.0018
667 DIABETES MELLITUS INADEQUATE CONTROL 31 0.0017
668 BEDRIDDEN 23 0.0017
669 SYNCOPE 175 0.0017
670 SUBDURAL HAEMATOMA 25 0.0017
671 PARALYSIS 25 0.0017
672 RETCHING 37 0.0017
673 NOCTURIA 21 0.0017
674 BLOOD POTASSIUM DECREASED 52 0.0017
675 SLEEP APNOEA SYNDROME 33 0.0017
676 FOETAL EXPOSURE DURING PREGNANCY 140 0.0017
677 ANGER 58 0.0017
678 HEPATIC FUNCTION ABNORMAL 64 0.0017
679 FEBRILE NEUTROPENIA 113 0.0017
680 PREMATURE BABY 51 0.0017
681 ATRIAL FIBRILLATION 165 0.0017
682 DRUG ERUPTION 30 0.0017
683 RESPIRATORY TRACT INFECTION 44 0.0017
684 BLOOD PRESSURE DECREASED 112 0.0017
685 HAEMOGLOBIN DECREASED 173 0.0017
686 SUBARACHNOID HAEMORRHAGE 17 0.0017
687 LACTIC ACIDOSIS 54 0.0017
688 LYMPHADENOPATHY 59 0.0017
689 DEHYDRATION 222 0.0017
690 DRUG INEFFECTIVE 2190 0.0017
691 OFF LABEL USE 1441 0.0016
692 FALL 545 0.0016
693 DEPRESSION 372 0.0016
694 BLOOD THYROID STIMULATING HORMONE INCREASED 15 0.0016
695 BLOOD BILIRUBIN INCREASED 44 0.0016
696 DENTAL CARIES 18 0.0016
697 MATERNAL EXPOSURE DURING PREGNANCY 145 0.0016
698 SMALL INTESTINAL OBSTRUCTION 20 0.0016
699 BLISTER 91 0.0016
700 BLOOD CHOLESTEROL INCREASED 75 0.0016
701 STAPHYLOCOCCAL INFECTION 53 0.0016
702 BLOOD IRON DECREASED 19 0.0016
703 CHOLECYSTITIS 19 0.0016
704 OEDEMA PERIPHERAL 192 0.0016
705 VOMITING 740 0.0016
706 NEURALGIA 38 0.0016
707 DRUG-INDUCED LIVER INJURY 49 0.0016
708 INITIAL INSOMNIA 16 0.0016
709 NEOPLASM PROGRESSION 54 0.0016
710 THERAPEUTIC RESPONSE DECREASED 94 0.0015
711 GAIT DISTURBANCE 295 0.0015
712 CANDIDA INFECTION 26 0.0015
713 ABASIA 38 0.0015
714 PETECHIAE 16 0.0015
715 CENTRAL NERVOUS SYSTEM LESION 21 0.0015
716 NEUROPATHY PERIPHERAL 145 0.0015
717 HEAD INJURY 48 0.0015
718 DRUG INTOLERANCE 146 0.0015
719 MOOD ALTERED 41 0.0015
720 COAGULOPATHY 25 0.0015
721 HEPATIC FAILURE 45 0.0015
722 BLOOD PRESSURE SYSTOLIC INCREASED 29 0.0015
723 DECREASED ACTIVITY 16 0.0015
724 NIGHTMARE 51 0.0015
725 MOUTH ULCERATION 31 0.0015
726 HEART RATE IRREGULAR 33 0.0015
727 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 76 0.0015
728 PERITONITIS 30 0.0014
729 DYSURIA 53 0.0014
730 BACTERAEMIA 17 0.0014
731 ANGINA PECTORIS 41 0.0014
732 DEVICE RELATED INFECTION 22 0.0014
733 FACE OEDEMA 24 0.0014
734 HEART RATE INCREASED 140 0.0014
735 DYSSTASIA 41 0.0014
736 URINARY TRACT INFECTION 239 0.0014
737 POOR QUALITY SLEEP 30 0.0014
738 ANAEMIA 265 0.0014
739 LIVER INJURY 34 0.0014
740 HAEMATURIA 46 0.0013
741 CHOLELITHIASIS 44 0.0013
742 ABDOMINAL PAIN 312 0.0013
743 DIALYSIS 19 0.0013
744 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 64 0.0013
745 BONE MARROW FAILURE 27 0.0013
746 DISEASE RECURRENCE 63 0.0013
747 PERIPHERAL COLDNESS 18 0.0013
748 DISEASE PROGRESSION 155 0.0013
749 JAUNDICE 35 0.0013
750 PRODUCTIVE COUGH 62 0.0013
751 THIRST 23 0.0013
752 SKIN LESION 35 0.0013
753 HOSPITALISATION 196 0.0013
754 VISION BLURRED 174 0.0013
755 ACTIVITIES OF DAILY LIVING IMPAIRED 25 0.0013
756 HYPOAESTHESIA ORAL 19 0.0013
757 INCORRECT ROUTE OF DRUG ADMINISTRATION 45 0.0013
758 RECTAL HAEMORRHAGE 54 0.0013
759 ACCIDENT 15 0.0013
760 LIVER DISORDER 55 0.0012
761 BALANCE DISORDER 107 0.0012
762 DRUG EXPOSURE DURING PREGNANCY 42 0.0012
763 MUSCULOSKELETAL CHEST PAIN 19 0.0012
764 MEMORY IMPAIRMENT 168 0.0012
765 HUNGER 17 0.0012
766 METASTASES TO BONE 20 0.0012
767 PANCREATITIS 64 0.0012
768 DRY MOUTH 97 0.0012
769 HIP FRACTURE 38 0.0012
770 HAEMORRHOIDS 23 0.0012
771 DECREASED APPETITE 273 0.0012
772 PNEUMONITIS 32 0.0012
773 LIVER FUNCTION TEST INCREASED 25 0.0012
774 COLITIS 44 0.0012
775 MULTIPLE FRACTURES 19 0.0012
776 ACUTE MYELOID LEUKAEMIA 18 0.0012
777 OEDEMA 62 0.0011
778 ABSCESS 18 0.0011
779 BACTERIAL INFECTION 21 0.0011
780 BRONCHOSPASM 16 0.0011
781 RENAL DISORDER 52 0.0011
782 HEPATIC ENZYME INCREASED 76 0.0011
783 ADVERSE DRUG REACTION 99 0.0011
784 MALIGNANT NEOPLASM PROGRESSION 112 0.0011
785 BLOOD GLUCOSE ABNORMAL 20 0.0011
786 CHEST PAIN 200 0.0011
787 COLD SWEAT 19 0.0011
788 HEAD DISCOMFORT 19 0.0011
789 WEIGHT DECREASED 298 0.0011
790 JOINT STIFFNESS 28 0.0011
791 ISCHAEMIC STROKE 19 0.0011
792 CARDIOVASCULAR DISORDER 27 0.0011
793 TOOTH LOSS 22 0.0011
794 RASH MACULAR 37 0.0011
795 GASTROINTESTINAL HAEMORRHAGE 88 0.0011
796 DYSPEPSIA 103 0.0010
797 BONE DISORDER 19 0.0010
798 PANIC ATTACK 38 0.0010
799 NERVOUSNESS 54 0.0010
800 FEMUR FRACTURE 32 0.0010
801 COMPLICATION ASSOCIATED WITH DEVICE 15 0.0010
802 BLINDNESS 42 0.0010
803 INFECTION 149 0.0010
804 ABDOMINAL PAIN LOWER 26 0.0010
805 BASAL CELL CARCINOMA 16 0.0010
806 MALAISE 449 0.0010
807 PRODUCT PRESCRIBING ISSUE 22 0.0010
808 PULMONARY HYPERTENSION 21 0.0010
809 TRANSIENT ISCHAEMIC ATTACK 34 0.0010
810 RASH GENERALISED 26 0.0010
811 MOOD SWINGS 32 0.0010
812 DRUG EFFECT INCOMPLETE 36 0.0010
813 DYSPNOEA 560 0.0010
814 ABDOMINAL DISTENSION 103 0.0010
815 CEREBRAL INFARCTION 24 0.0010
816 RENAL INJURY 29 0.0010
817 METASTASES TO LIVER 17 0.0010
818 LUNG DISORDER 47 0.0010
819 INTENTIONAL DRUG MISUSE 20 0.0010
820 MELAENA 21 0.0010
821 ASTHENIA 357 0.0009
822 ADVERSE EVENT 87 0.0009
823 FULL BLOOD COUNT DECREASED 19 0.0009
824 CYSTITIS 30 0.0009
825 OSTEOMYELITIS 17 0.0009
826 GASTROINTESTINAL DISORDER 84 0.0009
827 POLLAKIURIA 39 0.0009
828 UPPER RESPIRATORY TRACT INFECTION 43 0.0009
829 GAIT INABILITY 31 0.0009
830 ANAPHYLACTIC REACTION 51 0.0009
831 CHILLS 108 0.0009
832 LOCAL SWELLING 16 0.0009
833 CLOSTRIDIUM DIFFICILE INFECTION 20 0.0009
834 DRUG EFFECT DECREASED 49 0.0009
835 INTERSTITIAL LUNG DISEASE 44 0.0009
836 PRESCRIBED UNDERDOSE 18 0.0009
837 PLASMA CELL MYELOMA 35 0.0009
838 OSTEOARTHRITIS 38 0.0009
839 BLOOD URINE PRESENT 17 0.0009
840 DIARRHOEA 578 0.0009
841 GASTRIC ULCER 17 0.0009
842 GASTROOESOPHAGEAL REFLUX DISEASE 72 0.0009
843 INFLAMMATION 46 0.0009
844 MOBILITY DECREASED 64 0.0009
845 POST PROCEDURAL COMPLICATION 17 0.0009
846 ROAD TRAFFIC ACCIDENT 37 0.0009
847 RIB FRACTURE 18 0.0009
848 GLYCOSYLATED HAEMOGLOBIN INCREASED 22 0.0009
849 VIRAL INFECTION 29 0.0009
850 CEREBRAL HAEMORRHAGE 31 0.0009
851 NAUSEA 685 0.0009
852 DEATH 743 0.0009
853 HEART RATE DECREASED 30 0.0009
854 CRYING 31 0.0009
855 HEPATIC CIRRHOSIS 16 0.0009
856 SKIN ULCER 22 0.0009
857 DYSPNOEA EXERTIONAL 32 0.0008
858 CARDIAC DISORDER 79 0.0008
859 INTENTIONAL DOSE OMISSION 24 0.0008
860 CHROMATURIA 19 0.0008
861 RHINORRHOEA 54 0.0008
862 EMOTIONAL DISTRESS 101 0.0008
863 BLOOD PRESSURE FLUCTUATION 20 0.0008
864 TINNITUS 38 0.0008
865 COVID-19 144 0.0008
866 PRODUCT USE ISSUE 154 0.0008
867 THERAPY CESSATION 42 0.0008
868 KIDNEY INFECTION 16 0.0008
869 MUSCULAR WEAKNESS 92 0.0008
870 DISABILITY 16 0.0008
871 VISUAL IMPAIRMENT 100 0.0008
872 INJURY 56 0.0008
873 BLOOD PRESSURE INCREASED 121 0.0008
874 HAEMOPTYSIS 22 0.0008
875 FAECES DISCOLOURED 17 0.0008
876 SWELLING FACE 51 0.0008
877 MYALGIA 133 0.0008
878 DRUG ADMINISTRATION ERROR 24 0.0008
879 ANAPHYLACTIC SHOCK 20 0.0008
880 RASH ERYTHEMATOUS 37 0.0008
881 NECK PAIN 43 0.0008
882 EYE DISORDER 25 0.0008
883 CORONARY ARTERY DISEASE 23 0.0008
884 OCULAR HYPERAEMIA 36 0.0008
885 PRODUCT PRESCRIBING ERROR 18 0.0008
886 BLOOD GLUCOSE INCREASED 142 0.0008
887 WHEEZING 44 0.0007
888 DIPLOPIA 19 0.0007
889 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 17 0.0007
890 MUSCLE SPASMS 133 0.0007
891 FEELING ABNORMAL 173 0.0007
892 DIZZINESS 359 0.0007
893 WOUND 20 0.0007
894 CEREBROVASCULAR ACCIDENT 120 0.0007
895 INTENTIONAL PRODUCT USE ISSUE 62 0.0007
896 FATIGUE 550 0.0007
897 LACRIMATION INCREASED 21 0.0007
898 PALPITATIONS 81 0.0007
899 LIP SWELLING 23 0.0007
900 ABORTION SPONTANEOUS 27 0.0007
901 OROPHARYNGEAL PAIN 62 0.0007
902 INCORRECT DOSE ADMINISTERED 149 0.0007
903 FEELING HOT 40 0.0007
904 ALOPECIA 128 0.0007
905 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 22 0.0007
906 COUGH 182 0.0006
907 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 19 0.0006
908 CONTUSION 61 0.0006
909 DYSPHONIA 37 0.0006
910 OSTEOPOROSIS 26 0.0006
911 MYOCARDIAL INFARCTION 110 0.0006
912 THERAPEUTIC PRODUCT EFFECT DECREASED 28 0.0006
913 PERIPHERAL SWELLING 96 0.0006
914 CATARACT 37 0.0006
915 HAEMATOMA 16 0.0006
916 HYPERSENSITIVITY 114 0.0006
917 VERTIGO 37 0.0006
918 WRONG TECHNIQUE IN DRUG USAGE PROCESS 22 0.0006
919 EPISTAXIS 45 0.0006
920 CARDIAC FAILURE CONGESTIVE 48 0.0006
921 DISCOMFORT 36 0.0006
922 FLATULENCE 33 0.0006
923 STOMATITIS 35 0.0006
924 DEAFNESS 15 0.0006
925 UNEVALUABLE EVENT 43 0.0006
926 THERAPEUTIC RESPONSE UNEXPECTED 25 0.0006
927 MIGRAINE 53 0.0006
928 THROMBOSIS 44 0.0005
929 ABNORMAL DREAMS 15 0.0005
930 ABDOMINAL PAIN UPPER 110 0.0005
931 SKIN EXFOLIATION 45 0.0005
932 HAEMATOCHEZIA 29 0.0005
933 FLUID RETENTION 26 0.0005
934 SKIN DISORDER 17 0.0005
935 BACK PAIN 118 0.0005
936 PRURITUS 191 0.0005
937 HYPOAESTHESIA 74 0.0005
938 PAIN 300 0.0005
939 HEADACHE 305 0.0005
940 CHEST DISCOMFORT 48 0.0005
941 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 33 0.0005
942 LUNG NEOPLASM MALIGNANT 19 0.0005
943 ACNE 35 0.0005
944 SURGERY 27 0.0005
945 MUSCULOSKELETAL PAIN 24 0.0005
946 EYE SWELLING 17 0.0005
947 ERYTHEMA 93 0.0005
948 RASH 197 0.0005
949 HOT FLUSH 34 0.0005
950 BONE PAIN 26 0.0004
951 SWELLING 41 0.0004
952 ABDOMINAL DISCOMFORT 73 0.0004
953 NEOPLASM MALIGNANT 29 0.0004
954 BRONCHITIS 32 0.0004
955 ILL-DEFINED DISORDER 26 0.0004
956 INFLUENZA LIKE ILLNESS 35 0.0004
957 DRUG DEPENDENCE 67 0.0004
958 HAEMORRHAGE 43 0.0004
959 ARTHRITIS 32 0.0004
960 PRODUCT SUBSTITUTION ISSUE 23 0.0004
961 BLOOD GLUCOSE DECREASED 19 0.0004
962 PARAESTHESIA 62 0.0004
963 ECZEMA 20 0.0004
964 ARTHROPATHY 21 0.0004
965 NEPHROLITHIASIS 17 0.0004
966 SKIN DISCOLOURATION 17 0.0004
967 RASH PRURITIC 20 0.0004
968 JOINT SWELLING 43 0.0004
969 PAIN IN EXTREMITY 104 0.0004
970 FLUSHING 35 0.0003
971 UNDERDOSE 25 0.0003
972 INFLUENZA 38 0.0003
973 PRODUCT DOSE OMISSION 21 0.0003
974 ARTHRALGIA 125 0.0003
975 DRY EYE 15 0.0003
976 THERAPY INTERRUPTED 21 0.0003
977 NASOPHARYNGITIS 54 0.0003
978 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 51 0.0003
979 DRUG DOSE OMISSION 46 0.0003
980 NO ADVERSE EVENT 49 0.0003
981 BREAST CANCER 25 0.0003
982 ASTHMA 30 0.0003
983 PRODUCT QUALITY ISSUE 36 0.0003
984 BURNING SENSATION 17 0.0002
985 PRODUCT DOSE OMISSION ISSUE 71 0.0002
986 URTICARIA 40 0.0002
987 ACCIDENTAL EXPOSURE TO PRODUCT 24 0.0002
988 DYSGEUSIA 17 0.0002
989 ILLNESS 22 0.0002
990 PSORIASIS 27 0.0002
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35 0.0002
992 SINUSITIS 17 0.0002
993 DRY SKIN 20 0.0001
994 INJECTION SITE PAIN 38 0.0001